Shinako Araki
- Oncology top 10%
- Molecular Biology
- Cancer Research top 10%
- Immunology
- Pulmonary and Respiratory Medicine
- Co-authors
- David A. BoothmanLindsey D. MayoKonstantin LeskovTracy CriswellBal L. LokeshwarRajendra K. SinghVinata B. LokeshwarDmitry Klokov
- Topics
- Clusterin in disease pathology (8 papers)Biomarkers in Disease Mechanisms (5 papers)Cell death mechanisms and regulation (2 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- United StatesJapanSri Lanka
In The Last Decade
Shinako Araki
13 papers receiving 678 citations
Peers
Comparison fields: 5 of 71
- Oncology 400
- Molecular Biology 335
- Cancer Research 166
- Immunology 161
- Pulmonary and Respiratory Medicine 132
Countries citing papers authored by Shinako Araki
This map shows the geographic impact of Shinako Araki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinako Araki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinako Araki more than expected).
Fields of papers citing papers by Shinako Araki
This network shows the impact of papers produced by Shinako Araki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinako Araki. The network helps show where Shinako Araki may publish in the future.
Co-authorship network of co-authors of Shinako Araki
This figure shows the co-authorship network connecting the top 25 collaborators of Shinako Araki. A scholar is included among the top collaborators of Shinako Araki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinako Araki. Shinako Araki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Gosha-jinki-gan, a herbal medicine, is effective for the treatment of female patients with overactive bladder and sensitivity to the cold | 0 |
| 2 | 10 | |
| 3 | 24 | |
| 4 | 39 | |
| 5 | 35 | |
| 6 | 112 | |
| 7 | 233 | |
| 8 | BIRM, an Andean plant extract, down regulates androgen receptor and shows anti-tumor activity in prostate cancer | 1 |
| 9 | 22 | |
| 10 | 126 | |
| 11 | 14 | |
| 12 | 67 | |
| 13 | 4 | |
| 14 | 3 |
About Shinako Araki
Shinako Araki is a scholar working on Oncology, Immunology and Cancer Research, having authored 14 papers that have together received 690 indexed citations. Recurring topics across this work include Clusterin in disease pathology (8 papers), Biomarkers in Disease Mechanisms (5 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Oncology (400 citations), Cancer Research (166 citations) and Immunology (161 citations). Shinako Araki has collaborated with scholars based in United States, Japan and Sri Lanka. Frequent co-authors include David A. Boothman, Lindsey D. Mayo, Konstantin Leskov, Tracy Criswell, Bal L. Lokeshwar, Rajendra K. Singh, Vinata B. Lokeshwar, Dmitry Klokov, Xian‐Jin Xie and David Danielpour. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.